Praxis Precision Medicines, Inc.PRAXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+19.9%
5Y CAGR+42.8%
Year-over-Year Change
Research and development spending
3Y CAGR
+19.9%/yr
vs +69.4%/yr prior
5Y CAGR
+42.8%/yr
Recent deceleration
Acceleration
-49.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $267.12M | +75.3% |
| 2024 | $152.41M | +75.7% |
| 2023 | $86.77M | -44.0% |
| 2022 | $155.04M | +28.9% |
| 2021 | $120.26M | +167.4% |
| 2020 | $44.98M | +52.2% |
| 2019 | $29.56M | +57.1% |
| 2018 | $18.82M | - |